Prescription digital therapy to treat ADHD appears feasible
A study found statistically significant improvement in ADHD symptoms in children who wore the Revibe Connect device to school, according to a press release.
The results of the study were announced by Revibe Technologies, a digital therapeutics company, on the efficacy of FokusRx, an investigational software as a medical device.
Other Articles in this Edition
MRI Scans Show Few Brain Differences in Children with ADHD
Behavioral treatments for ADHD: For which children do they work?
Ohio’s child behavioral health system is at a ‘breaking point’
Prescription digital therapy to treat ADHD appears feasible